Staphylococcus aureus supernatant induces the release of mouse β-defensin-14 from osteoblasts via the p38 MAPK and NF-κB pathways

International Journal of Molecular Medicine

Volumn 31, Issue 6, 2013, Pages 1484-1494

  Zhu, Chen ^a   Qin, Hui ^a   Cheng, Tao ^a   Tan, Hong Lue ^a   Guo, Yong Yuan ^a   Shi, Si Feng ^a   Chen, De Sheng ^a   Zhang, Xian Long ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

defensin; Innate immunity; Osteoblast; Signaling pathway; Staphylococcus

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 14; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; ENZYME ACTIVATION; INNATE IMMUNITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SUPERNATANT;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-DEFENSINS; CELL LINE; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; CYTOKINES; INFLAMMATION MEDIATORS; MICE; MICROBIAL SENSITIVITY TESTS; NF-KAPPA B; OSTEOBLASTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS;

EID: 84876353849     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1346     Document Type: Article

References (38)

1. Montanaro L, Speziale P, Campoccia D, et al: Scenery of Staphylococcus implant infections in orthopedics. Future Microbiol 6: 1329-1349, 2011.
2. Marriott I, Gray DL, Rati DM, et al: Osteoblasts produce monocyte chemoattractant protein-1 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue. Bone 37: 504-512, 2005. (Pubitemid 41317324)
3. Ning R, Zhang X, Guo X and Li Q: Staphylococcus aureus regulates secretion of interleukin-6 and monocyte chemoattractant protein-1 through activation of nuclear factor kappaB signaling pathway in human osteoblasts. Braz J Infect Dis 15: 189-194, 2011.
4. Warnke PH, Springer IN, Russo PA, et al: Innate immunity in human bone. Bone 38: 400-408, 2006. (Pubitemid 43255435)
5. Campoccia D, Montanaro L, Speziale P and Arciola CR: Antibiotic-loaded biomaterials and the risks for the spread of antibiotic resistance following their prophylactic and therapeutic clinical use. Biomaterials 31: 6363-6377, 2010.
6. Shi Z, Neoh KG, Kang ET, Poh C and Wang W: Titanium with surface-grafted dextran and immobilized bone morphogenetic protein-2 for inhibition of bacterial adhesion and enhancement of osteoblast functions. Tissue Eng Part A 15: 417-426, 2009.
7. Kumarasamy KK, Toleman MA, Walsh TR, et al: Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10: 597-602, 2010.
8. Zuo GY, An J, Han J, et al: Isojacareubin from the Chinese Herb Hypericum japonicum: potent antibacterial and synergistic effects on clinical methicillin-resistant Staphylococcus aureus (MRSA). Int J Mol Sci 13: 8210-8218, 2012.
9. Hancock RE: Mechanism of action of newer antibiotics for gram-positive pathogens. Lancet Infect Dis 5: 209-218, 2005. (Pubitemid 40410066)
10. Pazgier M, Hoover DM, Yang D, Lu W and Lubkowski J: Human beta-defensins. Cell Mol Life Sci 63: 1294-1313, 2006.
11. Maisetta G, Batoni G, Esin S, Florio W, Bottai D, Favilli F and Campa M: In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains. Antimicrob Agents Chemother 50: 806-809, 2006. (Pubitemid 43191008)
12. Zhu C, Tan H, Cheng T, et al: Human defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation. J Surg Res: Dec 20, 2012 (Epub ahead of print).
13. Yamaguchi Y, Nagase T, Makita R, et al: Identification of multiple novel epididymis-specific beta-defensin isoforms in humans and mice. J Immunol 169: 2516-2523, 2002. (Pubitemid 34920996)
14. Hinrichsen K, Podschun R, Schubert S, Schröder JM, Harder J and Proksch E: Mouse beta-defensin-14, an antimicrobial ortholog of human beta-defensin-3. Antimicrob Agents Chemother 52: 1876-1879, 2008. (Pubitemid 351614694)
15. Röhrl J, Yang D, Oppenheim JJ and Hehlgans T: Identification and biological characterization of mouse beta-defensin 14, the orthologue of human beta-defensin 3. J Biol Chem 283: 5414-5419, 2008.
16. Ahrens K, Schunck M, Podda GF, et al: Mechanical and metabolic injury to the skin barrier leads to increased expression of murine defensin-1, -3, and -14. J Invest Dermatol 131: 443-452, 2011.
17. Lee HY, Takeshita T, Shimada J, et al: Induction of beta defensin 2 by NTHi requires TLR2 mediated MyD88 and IRAK-TRAF6-p38 MAPK signaling pathway in human middle ear epithelial cells. BMC Infect Dis 8: 87, 2008.
18. Hussain T, Nasreen N, Lai Y, Bellew BF, Antony VB and Mohammed KA: Innate immune responses in murine pleural mesothelial cells: toll-like receptor-2 dependent induction of beta-defensin-2 by staphylococcal peptidoglycan. Am J Physiol Lung Cell Mol Physiol 295: L461-L470, 2008.
19. Varoga D, Wruck CJ, Tohidnezhad M, et al: Osteoblasts participate in the innate immunity of the bone by producing human beta defensin-3. Histochem Cell Biol 131: 207-218, 2009.
20. Die L, Yan P, Jun Jiang Z, Min Hua T, Cai W and Xing L: Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts. Mol Immunol 52: 38-49, 2012.
21. Nihonyanagi S, Kanoh Y, Okada K, et al: Clinical usefulness of multiplex PCR lateral flow in MRSA detection: a novel, rapid genetic testing method. Inflammation 35: 927-934, 2012.
22. Suzuki A, Guicheux J, Palmer G, et al: Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone 30: 91-98, 2002. (Pubitemid 34044306)
23. Han SH, Kim KH, Han JS, et al: Response of osteoblast-like cells cultured on zirconia to bone morphogenetic protein-2. J Periodontal Implant Sci 41: 227-233, 2011.
24. Gläser R, Harder J, Lange H, Bartels J, Christophers E and Schröder JM: Antimicrobial psoriasin (S100A7) protects human skin from E. coli infection. Nat Immunol 6: 57-64, 2005.
25. Menzies BE and Kenoyer A: Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human beta-defensin 3 in skin keratinocytes. Infect Immun 74: 6847-6854, 2006. (Pubitemid 44913160)
26. An N, Rausch-fan X, Wieland M, Matejka M, Andrukhov O and Schedle A: Initial attachment, subsequent cell proliferation/viability and gene expression of epithelial cells related to attachment and wound healing in response to different titanium surfaces. Dent Mater 28: 1207-1214, 2012.
27. Li JY, Huang JY, Li M, et al: Anisomycin induces glioma cell death via down-regulation of PP2A catalytic subunit in vitro. Acta Pharmacol Sin 33: 935-940, 2012.
28. Tan H, Peng Z, Li Q, Xu X, Guo S and Tang T: The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant Staphylococcus. Biomaterials 33: 365-377, 2012.
29. Bar-Yehuda S, Luger D, Ochaion A, et al: Inhibition of experimental auto-immune uveitis by the A3 adenosine receptor agonist CF101. Int J Mol Med 28: 727-31, 2011.
30. Jang BC, Lim KJ, Paik JH, et al: Up-regulation of human beta-defensin 2 by interleukin-1 beta in A549 cells: involvement of PI3K, PKC, p38 MAPK, JNK, and NF-kappaB. Biochem Biophys Res Commun 320: 1026-1033, 2004.
31. Shim KS, Kang JS, Lee MH and Ma JY: Selaginella tamariscina water extract inhibits receptor activator for the nuclear factor-?B ligand-induced osteoclast differentiation by blocking mitogen-activated protein kinase and NF-?B signaling. Pharmacogn Mag 8: 184-191, 2012.
32. Mineshiba J, Myokai F, Mineshiba F, Matsuura K, Nishimura F and Takashiba S: Transcriptional regulation of beta-defensin-2 by lipopolysaccharide in cultured human cervical carcinoma (HeLa) cells. FEMS Immunol Med Microbiol 45: 37-44, 2005. (Pubitemid 40848709)
33. Hu DL, Omoe K, Sashinami H, Shinagawa K and Nakane A: Immunization with a nontoxic mutant of staphylococcal enterotoxin A, SEAD227A, protects against enterotoxin-induced emesis in house musk shrews. J Infect Dis 199: 302-310, 2009.
34. Rasooly R and Hernlem B: TNF as biomarker for rapid quantification of active Staphylococcus enterotoxin A in food. Sensors (Basel) 12: 5978-5985, 2012.
35. Lucke M, Schmidmaier G, Sadoni S, et al: Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone 32: 521-531, 2003. (Pubitemid 39665711)
36. Semple F, MacPherson H, Webb S, et al: Human defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF. Eur J Immunol 41: 3291-3300, 2011.
37. Lai Y and Gallo RL: AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30: 131-141, 2009.
38. Röhrl J, Yang D, Oppenheim JJ and Hehlgans T: Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol 184: 6688-6694, 2010